Journal Basic Info

  • Impact Factor: 2.709**
  • H-Index: 11 
  • ISSN: 2474-1663
  • DOI: 10.25107/2474-1663
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.

Major Scope

  •  Radiological Techniques and Scans
  •  Stomach Cancer
  •  Pancreatic Cancer
  •  Kidney Cancer
  •  Head and Neck Oncology
  •  Hormone Therapy
  •  Hematology
  •  Adjuvant Therapy

Abstract

Citation: Clin Oncol. 2019;4(1):1666.DOI: 10.25107/2474-1663.1666

Case Report of Pathologically Confirmed Complete Response of Metastatic Breast Cancer after Long Term Experimental Antiangiogenic Treatment as Addition to Standard Therapeutic Approach

Mariani G, Galli G, Marchianò A , Regalia E , Gianni L and Valagussa P

Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Italy Department of Radiology, Fondazione IRCCS Istituto Nazionale Tumori, Italy Fondazione IRCCS Istituto Nazionale Tumori, Italy Department of Medical Oncology, San Raffaele Hospital Scientific Institute, Italy Fondazione Michelangelo, Italy

*Correspondance to: Mariani Gabriella 

 PDF  Full Text Case Report | Open Access

Abstract:

Metastatic breast cancer otherwise called stage IV or advanced breast cancer is one among the unspecific types of cancer and is most advanced. It spreads to lymph nodes and to other organs but still considered as breast cancer. Metastatic Breast Cancer (MBC) has remained an incurable disease so Complete Response (CR) in MBC is rare. However survival rates of patients with Metastatic Breast Cancer has gradually prolonged over the past few years due to improvement of Antineoplastic agents.

Keywords:

Metastatic breast cancer; Antiangiogenic treatment; Sorafenib

Cite the Article:

Mariani G, Galli G, Marchianò A, Regalia E, Gianni L, Valagussa P. GTV Cochlea Distance to Predict the Case Report of Pathologically Confirmed Complete Response of Metastatic Breast Cancer after Long Term Experimental Antiangiogenic Treatment as Addition to Standard Therapeutic Approach. Clin Oncol. 2019;4:1666.

Search Our Journal

Journal Indexed In

Articles in PubMed

LINGO-1 is a New Therapy Target and Biomarker for Ewing Sarcoma
 PubMed  PMC  PDF  Full Text
Metastatic Retroperitoneal Paraganglioma: Case Report and Review of the Literature
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

Clinical Features and Gene Mutations of Disseminated Intravascular Coagulation Patients in Acute Promyelocytic Leukemia
 Abstract  PDF  Full Text
Absolute dPCR Quantification of MicroRNAs by Absolute dPCR for the Diagnostic Screening of Colon Cancer
 PDF  Full Text
View More...